Stock Price
18.79
Daily Change
-5.01%
Yearly
-66.45%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 7,070.00 -85.00 -1.19% -10.36%
Acadia Pharmaceuticals 18.79 -0.99 -5.01% -66.45%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
ALKERMES 22.47 -0.41 -1.79% 21.46%
Alnylam Pharmaceuticals 188.53 -0.27 -0.14% 45.18%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Aptinyx Inc 2.42 0.01 0.41% -36.48%
Arena Pharmaceuticals 57.42 -1.54 -2.61% -12.87%
Biogen 242.90 -7.23 -2.89% -0.36%
BioMarin Pharmaceutical 87.58 -1.99 -2.22% 8.93%
Bristol-Myers Squibb 56.53 -0.28 -0.49% -10.34%
Cara Therapeutics 12.80 -0.54 -4.05% -14.38%
Corcept Therapeutics 21.49 -0.97 -4.32% -6.52%
Cytokinetics 39.03 -1.87 -4.57% 127.58%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 17.10 -0.65 -3.66% -54.12%
Incyte Corp 68.38 1.64 2.46% -17.86%
Intra Cellular Therapies 42.45 -1.11 -2.55% 69.94%
J&J 159.20 -1.04 -0.65% 10.56%
Eli Lilly 260.37 -1.63 -0.62% 76.59%
Moderna Inc 329.63 56.24 20.57% 159.49%
Marinus Pharmaceuticals 11.29 -0.54 -4.56% -22.88%
Neurocrine Biosciences 86.98 -0.88 -1.00% -8.98%
Pfizer 54.00 3.11 6.11% 45.04%
Prothena 49.16 -4.49 -8.36% 335.39%
PTC Therapeutics 38.06 -1.35 -3.43% -40.52%
Ultragenyx Pharmaceutical 76.49 -1.09 -1.41% -37.52%
Seattle Genetics 169.50 -3.70 -2.14% 0.22%
Sarepta Therapeutics 79.62 -1.36 -1.68% -42.78%
Vanda Pharmaceuticals 16.55 -0.78 -4.50% 33.36%
Vertex Pharmaceuticals 183.59 -2.65 -1.42% -19.02%
Zogenix 11.70 -0.59 -4.80% -45.73%

Indexes Price Day Year
US2000 2246 -85.52 -3.67% 21.06%
NASDAQ 15492 -353.57 -2.23% 26.92%

Acadia Pharmaceuticals
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).